Provided By GlobeNewswire
Last update: May 29, 2025
Southlake, TX, May 29, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (“AI”)-powered medical technology company focused on transforming ECGs/EKGs to enable earlier detection of heart disease, today announced the signing of its first commercial customer for the MyoVista Insights™ platform: Westcliffe Health Innovations, based in the United Kingdom.
Read more at globenewswire.comNASDAQ:HSCSW (6/13/2025, 8:07:27 PM)
0.14
+0.09 (+167.69%)
3.5734
-0.03 (-0.74%)
Find more stocks in the Stock Screener